TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pelago Bioscience AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
8,366
|
7,893
|
7,440 |
| Financial expenses |
5
|
1
|
5 |
| Earnings before taxes |
-1,428
|
-638
|
515 |
| EBITDA |
-1,047
|
-492
|
979 |
| Total assets |
7,520
|
8,277
|
6,441 |
| Current assets |
4,915
|
5,535
|
5,098 |
| Current liabilities |
3,159
|
3,084
|
3,406 |
| Equity capital |
4,361
|
5,185
|
2,810 |
| - share capital |
10
|
10
|
5 |
| Employees (average) |
56
|
52
|
51 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
58.0%
|
62.6%
|
43.6% |
| Turnover per employee |
149
|
152
|
146 |
| Profit as a percentage of turnover |
-17.1%
|
-8.1%
|
6.9% |
| Return on assets (ROA) |
-18.9%
|
-7.7%
|
8.1% |
| Current ratio |
155.6%
|
179.5%
|
149.7% |
| Return on equity (ROE) |
-32.7%
|
-12.3%
|
18.3% |
| Change turnover |
741
|
432
|
804 |
| Change turnover % |
10%
|
6%
|
12% |
| Chg. No. of employees |
4
|
1
|
12 |
| Chg. No. of employees % |
8%
|
2%
|
31% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.